CompletedNCT00725244
Official study titleA Randomized Prospective Study of Endoscopy Bipolar Eletrocoagulation and Argon Plasma Coagulation of Chronic Rectal Bleeding From Radiation Telangiectasias
This study has finished and is no longer accepting participants.
In São PauloBipolarityDevice studyAges 18–88
- Countries
- Brazil
- Sponsor
- Federal University of São Paulo
CompletedNCT01076361
Official study titleMedtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
This study has finished and is no longer accepting participants.
Multiple locations, including AnchorageBipolarityObservational study
- Countries
- United States, Australia, France, + 11 others
- Sponsor
- Medtronic
RecruitingNCT04777357
About this title
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
Read the official source — NCT04777357What is this study about?Researchers are comparing Cariprazine and placebo, tracking side effects to assess safety in children with bipolarity type I.
Multiple locations, including AnaheimBipolarity, DepressionMedication studyAges 10–17
- Countries
- United States, Russia
- Sponsor
- AbbVie
RecruitingNCT06372964
About this title
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Read the official source — NCT06372964What is this study about?Researchers are comparing Lumateperone and placebo, tracking side effects to assess safety in children with bipolarity type II during a depressive episode.
Multiple locations, including DothanBipolarity, DepressionMedication studyAges 10–17
- Countries
- United States, Colombia, India, + 1 other
- Sponsor
- Intra-Cellular Therapies, Inc.
RecruitingNCT03522545
About this title
Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression
Read the official source — NCT03522545Official study titleAdjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression
In HoustonDepression, BipolarityPlacebo comparisonAges 18–65
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
RecruitingNCT06656416
About this title
ALTO-100 in Bipolar Disorder With Depression (BD-D)
Read the official source — NCT06656416What is this study about?Researchers are comparing ALTO-100 and placebo to find out how the approaches affect depression symptoms in adults with bipolarity during a depressive episode.
Multiple locations, including PhoenixBipolarity, DepressionMedication studyAges 18–70
- Countries
- United States, United Kingdom
- Sponsor
- Alto Neuroscience